Tolazoline

An α2 adrenoceptor antagonist
  • C04AB02 (WHO) M02AX02 (WHO) QV03AB94 (WHO)
Identifiers
  • 2-Benzyl-4,5-dihydro-1H-imidazole
CAS Number
  • 59-98-3 checkY
PubChem CID
  • 5504
IUPHAR/BPS
  • 7310
DrugBank
  • DB00797 checkY
ChemSpider
  • 5303 checkY
UNII
  • CHH9H12AQ3
KEGG
  • D08614 checkY
ChEBI
  • CHEBI:28502 checkY
ChEMBL
  • ChEMBL770 checkY
CompTox Dashboard (EPA)
  • DTXSID3023683 Edit this at Wikidata
ECHA InfoCard100.000.408 Edit this at WikidataChemical and physical dataFormulaC10H12N2Molar mass160.220 g·mol−13D model (JSmol)
  • Interactive image
  • N\1=C(\NCC/1)Cc2ccccc2
InChI
  • InChI=1S/C10H12N2/c1-2-4-9(5-3-1)8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12) checkY
  • Key:JIVZKJJQOZQXQB-UHFFFAOYSA-N checkY
  (verify)

Tolazoline is a non-selective competitive α-adrenergic receptor antagonist.[1] It is a vasodilator that is used to treat spasms of peripheral blood vessels (as in acrocyanosis). It has also been used (in conjunction with sodium nitroprusside) successfully as an antidote to reverse the severe peripheral vasoconstriction which can occur as a result of overdose with certain 5-HT2A agonist drugs such as 25I-NBOMe,[2] DOB and Bromodragonfly (prolonged severe vasoconstriction can lead to gangrene if untreated).[3][4]

It is however most commonly used in veterinary medicine, to reverse xylazine-induced sedation.[5][6]

References

  1. ^ Aronson, J. K. (2016). Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions. Amsterdam: Elsevier Science. ISBN 978-0-444-53717-1. OCLC 927102885. Tolazoline is an α2 adrenoceptor antagonist that increases skin blood flow in healthy subjects and has been used to relieve acute vasospasm.
  2. ^ "Human Metabolome Database: Showing metabocard for Tolazoline (HMDB0014935)". hmdb.ca. Retrieved 2022-02-03.
  3. ^ Bowen JS, Davis GB, Kearney TE, Bardin J (March 1983). "Diffuse vascular spasm associated with 4-bromo-2,5-dimethoxyamphetamine ingestion". JAMA. 249 (11): 1477–9. doi:10.1001/jama.1983.03330350053028. PMID 6827726.
  4. ^ Thorlacius K, Borna C, Personne M (2008). "[Bromo-dragon fly--life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case]". Läkartidningen (in Swedish). 105 (16): 1199–200. PMID 18522262.
  5. ^ Boothe DM (2001). "Anticonvulsant drugs and analeptic agents". In Adams HR (ed.). Veterinary pharmacology and therapeutics. Ames: Iowa State University Press. pp. 378–9. ISBN 0-8138-1743-9. Retrieved 8 September 2008.
  6. ^ Hall LW, Clarke KW, Trim CM (2001). "Principles of sedation, analgesia and premedication". Veterinary anaesthesia. Philadelphia: W.B. Saunders. pp. 90–1. ISBN 0-7020-2035-4.
  • v
  • t
  • e
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Dopaminergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins